Page 2 - Flipbook
P. 2

Colour Legend      Managed by PCP             Managed by specialist     Managed by PCP and specialist


                                                     ADT Adverse Events
          Adverse event                Management (assess every 6-12 months while on therapy)    Date:  MM/DD/YY

          Bone health                  Avoid alcohol while on therapy                    Alcohol consumption  Yes  No
          Decreased bone mineral density
          Increase risk for osteoporosis    Calcium and vitamin D supplementation        Receiving recommended doses?
          Increased risk for clinical fractures  * Recommend calcium 1200 mg PO daily from dietary sources and       Yes  No
                                       supplements and vitamin D 800-2000 IU PO daily
                                       Baseline calcium level                            Screening?  Yes  No
                                                                                         Osteopenia?  Yes  No
                                       Baseline 25-hydroxyvitamin D level
                                                                                         Osteoporosis?  Yes  No
                                       Osteoporosis screening and management
                                                                                         Treatment indicated?  Yes  No
                                       For men with expected duration of therapy >1 year:
                                                                                         Details of treatment:
                                       Baseline bone mineral density
                                       *Men on ADT are at increased risk for osteoporosis and clinical fractures. Recommend
                                       screening and management of osteoporosis as per the 2010 clinical practice guidelines for
                                       the diagnosis and management of osteoporosis in Canada for all men on ADT *DXA should
                                       be repeated every 2–3 years in men at low risk for fractures receiving ADT. In men with
                                       osteopenia or those at moderate or high risk for fractures, DXA should be repeated every
                                       1–2 years until treatment cessation. Patients started on pharmacological therapy should
                                       have followup DXA to assess for treatment response.
          Hot flashes                  Identify and avoid triggers                       Hot flashes  Yes  No
          Feeling hot and experiencing sweats  Various medications are available and may help your symptoms
                                       Consider acupuncture
          Breast events                If you are experiencing this side effect let your prostate cancer doctor   Breast events  Yes  No
          Breast growth and/or tenderness  know. There may be treatment options available, including hormone
                                       therapies, radiation and surgery.

          Cognitive function           Monitor your symptoms and let your providers know if you experience   Changes in cognition  Yes  No
          Possibly decreased concentration,   any changes.
          memory loss, dementia and depression

          Fatigue and anemia           Exercising regularly helps with fatigue.          Fatigue  Yes  No
          Feeling tired and low hemoglobin levels  Work up secondary causes of anemia and referral to hematology if
                                       hemoglobin level drops more than 10mg/dL          Last HGB level
          Impaired sexual function     You may benefit from seeing a sex therapist or medications and other   Sexual dysfunction?  Yes  No
          Decreased penile and testicular size   interventions to help with sexual function
          Loss of sexual desire        Discuss with your prostate cancer doctor if intermittent ADT may be
          Decreased sensitivity to sexual   appropriate for you
          stimulation
          Erectile dysfuncton

          Quality of life              Exercising regularly helps improve quality of life while you are on ADT.
          Multiple domains             Discuss with your prostate cancer doctor if intermittent ADT may be
                                       appropriate for you

        Source: Kokorovic A, So AI, Rendon R et al. Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies. Can Urol Assoc
        J. 2021;15(6):E307-E322. doi:10.5489/cuaj.7355
        Reference: Papaioannou A, Morin S, Leslie WD et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. CMAJ. 2010;182:
        1864–73. doi: 10.1503/cmaj.100771















        This tool was developed by the CUA and made possible with funding provided by Abbvie, Ferring and Sanofi in collaboration with Tolmar.
   1   2